Serum galactomannan diagnosis of breakthrough invasive fungal disease
- PMID: 25628384
- DOI: 10.1093/cid/civ035
Serum galactomannan diagnosis of breakthrough invasive fungal disease
Comment in
-
Reply to Lewis et al.Clin Infect Dis. 2015 Apr 15;60(8):1285. doi: 10.1093/cid/civ036. Epub 2015 Jan 26. Clin Infect Dis. 2015. PMID: 25628382 No abstract available.
Comment on
-
Serum galactomannan-based early detection of invasive aspergillosis in hematology patients receiving effective antimold prophylaxis.Clin Infect Dis. 2014 Dec 15;59(12):1696-702. doi: 10.1093/cid/ciu673. Epub 2014 Aug 27. Clin Infect Dis. 2014. PMID: 25165088
Similar articles
-
Serum galactomannan-based early detection of invasive aspergillosis in hematology patients receiving effective antimold prophylaxis.Clin Infect Dis. 2014 Dec 15;59(12):1696-702. doi: 10.1093/cid/ciu673. Epub 2014 Aug 27. Clin Infect Dis. 2014. PMID: 25165088
-
Galactomannan testing during mold-active prophylaxis.Clin Infect Dis. 2014 Dec 15;59(12):1703-4. doi: 10.1093/cid/ciu677. Epub 2014 Aug 27. Clin Infect Dis. 2014. PMID: 25165089 Free PMC article. No abstract available.
-
[Usefulness of galactomannan detection in the diagnosis and follow-up of hematological patients with invasive aspergillosis].Rev Iberoam Micol. 2003 Sep;20(3):103-10. Rev Iberoam Micol. 2003. PMID: 15456366 Review. Spanish.
-
[Value of Aspergillus galactomannan antigen detection in the diagnosis and follow-up of invasive aspergillosis in hematological patients].Rev Iberoam Micol. 2003 Sep;20(3):116-8. Rev Iberoam Micol. 2003. PMID: 15456368 Clinical Trial. Spanish.
-
[Invasive aspergillosis].Rev Iberoam Micol. 2003 Sep;20(3):77-8. Rev Iberoam Micol. 2003. PMID: 15456362 Review. Spanish.
Cited by
-
Aspergillus fumigatus and Aspergillosis in 2019.Clin Microbiol Rev. 2019 Nov 13;33(1):e00140-18. doi: 10.1128/CMR.00140-18. Print 2019 Dec 18. Clin Microbiol Rev. 2019. PMID: 31722890 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical